|
VYNE Vyne Therapeutics Inc 1566044 |
| Balance Sheet |
|
Current Assets
|
64,437,000 |
|
Assets
|
66,905,000 |
|
Current Liabilities
|
14,819,000 |
|
Liabilities
|
14,819,000 |
|
Equity
|
52,086,000 |
|
Shares Out
|
14,749,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-33,972,000 |
|
Investing Cash Flow
|
23,365,000 |
| Market Analysis |
Market Cap
|
27,507,612 |
|
Price
|
1.73 |
|
BVPS
|
3.53 |
|
PB
|
0.50 |
|
EPS
|
-2.57 |
|
PS
|
13.73 |
|
FCF
|
-10,607,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VYNE documents filed with the SEC.
VYNE Filings
Clear
